Japanese BAY1000394 Monotherapy Phase I Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is an open-label, non-randomized, dose-escalating Phase I study to evaluate the safety, tolerability, pharmacokinetics of BAY1000394 given in a 3 days on / 4 days off schedule in Japanese subjects with advanced malignancies.
Epistemonikos ID: a371ec58c0f19103082790afaccc0ef3cd714f41
First added on: May 11, 2024